The American Academy of Ophthalmology (AAO) will hold its conference in person in Chicago and online from September 30 to October 3, 2022.
The American Academy of Ophthalmology (AAO) will be hosting its annual conference in Chicago, Illinois, from Friday, September 30 through Monday, October 3.
Sessions will be offered both in person and on demand, with live broadcasts also provided. The sessions will focus on various topics within the ophthalmology field, including addressing inclusivity in leadership, the future of telemedicine, and worldwide innovations.
The 4-day conference will also include sessions presenting new findings in glaucoma, cataract, and cornea research.
One highlight from the agenda is a symposium on new innovations in ophthalmology worldwide. The symposium, which will be in person, broadcasted live, and on demand, is cosponsored by the American Medical Association Ophthalmology Section Council. Speakers include James L. Madara, MD, and Grayson W. Armstrong, MD, who will talk about the future of medicine and optimizing telemedicine for eye care, respectively.
“We’ll also have cutting edge topics on retinal disease, and also [Lloyd B. Williams, MD, PhD, who] travels internationally, mostly to Africa, to deal with indigent and ophthalmic care in third-world countries,” symposium cochair Ravi D. Goel, MD, said in an interview with The American Journal of Managed Care®. “So ‘Innovations in Ophthalmology From Around the World’ is a must-visit event.”
A symposium on inclusivity in leadership in the ophthalmology field, entitled “Inclusive Leadership: Enhancing Delivery of Patient Care,” will also take place at AAO. The session, which Goel is also cochairing, will include 6 speakers to talk about what inclusive leadership means and how to cultivate that leadership in private practices.
“Our session on inclusive leadership brings together leaders from health care systems, ophthalmology departments, and private practices who will hopefully give our colleagues tools so that they can help to promote more inclusive leadership across ophthalmology and across health care,” Goel said.
Sessions at AAO 2022 will also focus on innovations and updates in glaucoma care. A session titled “Elevating Glaucoma Research Through Diversity” will focus on the benefits of broadening workforce diversity to improve the scope of research and potentially contribute to new ideas to address equity issues in glaucoma care.
Insights on how to manage patients with cataracts will also get a spotlight at this conference, as the agenda includes symposia titled “Managing Pediatric Cataract Patients: The Whole Story” and “Ophthalmic Premier League: A Team Symposium on Managing Cataract Complications.” These sessions will cover the role that intraocular lenses, glaucoma, access to care, and devices have on cataract care in both the pediatric and general populations.
The opening session of the conference on Friday will feature a lecture from author Scott Turow and the closing session will come on Monday afternoon with historian Doris Kearns Goodwin. Goodwin will be talking about her book Leadership in Turbulent Times.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More